Vanda Pharmaceuticals
Clinical trials sponsored by Vanda Pharmaceuticals, explained in plain language.
-
One-Patient trial aims to fix genetic glitch behind rare nerve disease
Disease control OngoingThis study tests a custom-made drug (VCA-894A) in a single person with a rare genetic nerve disease called CMT2S. The drug is designed to correct a specific genetic error and restore a missing protein. The main goals are to check if the treatment is safe and if it can improve mus…
Phase: PHASE1, PHASE2 • Sponsor: Vanda Pharmaceuticals • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC
-
Could this pill end travel sickness? new study tests tradipitant
Symptom relief OngoingThis study tests a drug called tradipitant to see if it safely eases motion sickness during travel. About 705 adults with a history of motion sickness will take the drug and report any side effects. The goal is to find a better way to prevent nausea and vomiting on the go.
Phase: PHASE3 • Sponsor: Vanda Pharmaceuticals • Aim: Symptom relief
Last updated May 01, 2026 21:26 UTC